Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12122832 TIM-3-targeting antibodies and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
June 7, 2023
0
Date of Patent
October 22, 2024
0
Patent Application Number
18330367
0
Patent Citations
‌
US Patent 8361736 Ex vivo methods for targeting or depleting acute myeloid leukemia cancer stem cells
0
‌
US Patent 8552156 Anti-TIM-3 antibody
0
‌
US Patent 8647623 Method for treatment of blood tumor using anti-TIM-3 antibody
0
‌
US Patent 8697069 Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells
0
‌
US Patent 8709412 Modulation of TIM receptor activity in combination with cytoreductive therapy
0
‌
US Patent 8709429 Markers of acute myeloid leukemia stem cells
0
‌
US Patent 9103832 Method for treatment of blood tumor using anti-TIM-3 antibody
0
‌
US Patent 9333256 Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells
0
‌
US Patent 9487591 Method for treatment of blood tumor using anti-TIM-3 antibody
0
‌
US Patent 9958446 Method for treatment of blood tumor using anti-TIM-3 antibody
0
•••
Patent Inventor Names
Haojie Wang
0
Jun Ma
0
Liegang Shao
0
Baiyang Wang
0
Dong Wang
0
Yu Zhang
0
Binbin Wang
0
Jinyu Dong
0
Xin Dong
0
Qian Gao
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12122832
0
Patent Primary Examiner
‌
Meera Natarajan
0

Find more entities like US Patent 12122832 TIM-3-targeting antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.